Acute experimental Trypanosoma cruzi infection: Establishing a murine model that utilises non-invasive measurements of disease parameters

Memorias do Instituto Oswaldo Cruz

Volumn 107, Issue 2, 2012, Pages 211-216

  da Silva, Diana Rodrigues ^a   de Castro, Solange Lisboa ^a   Alves, Monique Castro da Silva ^a   Batista, Wanderson da Silva ^a   de Oliveira, Gabriel Melo ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Clinical signs; Murine model; Non invasive parameters; Trypanosoma cruzi

Indexed keywords

HEXAPODA; MURINAE; MUS; TRYPANOSOMA CRUZI;

EID: 84857950488     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/s0074-02762012000200010     Document Type: Article

References (45)

1. Andrade SG, Campos RF, Sobral KS, Magalhães JB, Guedes RS, Guerreiro ML 2006. Reinfections with strains of Trypanosoma cruzi of different biodemes as a factor of aggravation of myocarditis and myositis in mice. Rev Soc Bras Med Trop 39: 1-8.
2. Araújo-Jorge TC 1989. The biology of Trypanosoma cruzi-macrophage interaction. Mem Inst Oswaldo Cruz 84: 441-462.
3. Araújo-Jorge TC, De Castro SL 2000. Questões da doença humana para trabalho em modelos animais. In TC Arau ́jo-Jorge, SL de Castro, Doença de Chagas: manual para experimentação animal, Editora Fiocruz, Rio de Janeiro, p. 17-19.
4. Babad J, Geliebter A, DiLorenzo TP 2010. T-cell auto antigens in the non-obese diabetic mouse model of autoimmune diabetes. Immunology 131: 459-465.
5. Bates JH, Rincon M, Irvin CG 2009. Animal models of asthma. Am J Physiol Lung Cell Mol Physiol 297: 401-410.
6. Beltrão B, Cerroni P, Freitas R, Pinto Y, Valente C, Valente A, Costa G, Sobel J 2009. Investigation of two outbreaks of suspected oral transmission of acute Chagas disease in the Amazon Region, Pará state, Brazil, in 2007. Trop Doct 39: 231-232.
7. Bossola M, Pacelli F, Doglietto GB 2007. Novel treatments for cancer, cachexia. Expert Opin Investig Drugs 16: 1241-1253.
8. Brener Z 1962. Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Rev Inst Med Trop Sao Paulo 4: 386-396.
9. Cerami A, Ikeda Y, Le Trang N, Hotez PJ, Beutler B 1985. Weight loss associated with an endotoxin-induced mediator from peritoneal macrophages: the role of cachectin (tumour necrosis factor). Immunol Lett 11: 173-177.
10. Chagas C 1909. Nova tripanozomiaze humana: estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem. Mem Inst Oswaldo Cruz 1: 159-218.
11. Coura JR 2000. A doença de Chagas humana e seus modelos de estudo. In TC Araújo-Jorge, SL de Castro. Doença de Chagas: manual para experimentação animal, Editora Fiocruz, Rio de Janeiro, p. 19-24.
12. Coura JR 2006. Transmission of chagasic infection by oral route in the natural history of Chagas disease. Rev Soc Bras Med Trop 39: 113-117.
13. Coura JR, Borges-Pereira J 2010. Chagas disease: 100 years after its discovery. A systemic review. Acta Trop 115: 5-13.
14. Cryan JF, Holmes A 2005. The ascent of mouse: advances in modeling human depression and anxiety. Nat Rev Drug Discov 4: 775-790.
15. Dias E 1934. Estudos sobre o Schizotrypanum cruzi. Mem Inst Oswaldo Cruz 28: 1-110.
16. Dias JC, Prata A, Correia D 2008. Problems and perspectives for Chagas disease control: in search of a realistic analysis. Rev Soc Bras Med Trop 41: 193-196.
17. Eickhoff CS, Lawrence CT, Sagartz JE, Bryant LA, Labovitz AJ, Gala SS, Hoft DF 2010. ECG detection of murine chagasic cardiomyopathy. J Parasitol 96: 758-764.
18. Emery PW 1999. Cachexia in experimental models. Nutrition 15: 600-603.
19. Johnstone LE, Higuchi T 2001. Food intake and leptin during pregnancy and lactation. Prog Brain Res 133: 215-227.
20. Kalamarides M, Peyre M, Giovannini M 2010. Meningioma mouse models. J Neurooncol 99: 325-331.
21. Kalueff AV, Fox MA, Gallagher PS, Murphy DL 2007. Hypolocomotion, anxiety and serotonin syndrome-like behaviour contribute to the complex phenotype of serotonin transporter knockout mice. Genes Brain Behav 6: 389-400.
22. Keeney A, Jessop DS, Harbuz MS, Marsden CA, Hogg S, Blackburn-Munro RE 2006. Differential effects of acute and chronic social defeat stress on hypothalamic-pituitary-adrenal axis function and hippocampal serotonin release in mice. J Neuroendocrinol 18: 330-338.
23. Lainscak M, Podbregar M, Anker SD 2007. How does cachexia influence survival in cancer, heart failure and other chronic diseases? Curr Opin Support Palliat Care 1: 299-305.
24. Lapchik V, Mattaraia V, Ko G 2009. Cuidados e manejos de animais de laboratório, Editora Ateneu, São Paulo, 697 pp.
25. Lenzi H, Oliveira D, Lima M, Gattass CR 1996. Trypanosoma cruzi: paninfectivity of CL strain during murine acute infection. Exp Parasitol 84: 16-27.
26. Lescure FX, Le Loup G, Freilij H, Develoux M, Paris L, Brutus L, Pialoux G 2010. Chagas disease: changes in knowledge and management. Lancet Infect Dis 10: 556-570.
27. Marinho CR, D'Império Lima MR, Grisotto MG, Alvarez JM 1999. Influence of acute-phase parasite load on pathology, parasitism and activation of the immune system at the late chronic phase of Chagas disease. Infect Immun 67: 308-318.
28. Matsumoto K, Pinna G, Puia G, Guidotti A, Costa E 2005. Social isolation stress-induced aggression in mice: a model to study the pharmacology of neurosteroidogenesis. Stress 8: 85-93.
29. Melo ES, Barbeiro HV, Ariga S, Goloubkova T, Curi R, Velasco IT, Vasconcelos D, Soriano FG 2010. Immune cells and oxidative stress in the endotoxin tolerance mouse model. Braz J Med Biol Res 43: 57-67.
30. Moncayo A, Silveira AC 2009. Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy. Mem Inst Oswaldo Cruz 104 (Suppl. I): 17-30.
31. Oliveira GM, Diniz RL, Batista W, Batista MM, Bani Correa C, Araújo-Jorge TC, Henriques-Pons A 2007. Fas ligand-dependent inflammatory regulation in acute myocarditis induced by Trypanosoma cruzi infection. Am J Pathol 171: 79-86.
32. Oliveira GM, Masuda MO, Rocha NN, Schor N, Hooper CS, Araújo- Jorge TC, Henriques-Pons A 2009a. Absence of Fas-L aggravates renal injury in acute Trypanosoma cruzi infection. Mem Inst Oswaldo Cruz 104: 1063-1071.
33. Oliveira GM, Silva T, Batista W, Franco M, Schor N 2009b. Acute Trypanosoma cruzi experimental infection-induced renal ischemic/ reperfusion lesion in mice. Parasitol Res 106: 111-120.
34. Park KS, Choi KH, Kim YS, Hong BS, Kim OY, Kim JH, Yoon CM, Koh GY, Kim YK, Gho YS 2010. Outer membrane vesicles derived from Escherichia coli induce systemic inflammatory response syndrome. PLoS ONE 5: e11334.
35. Pavanelli WR, Gutierrez FR, Mariano FS, Prado CM, Ferreira BR, Teixeira MM, Canetti C, Rossi MA, Cunha FQ, Silva JS 2010. 5-lipoxygenase is a key determinant of acute myocardial inflammation and mortality during Trypanosoma cruzi infection. Microbes Infect 12: 587-597.
36. Porto CC 2010. Semiologia Médica, 5th ed., Editora Guanabara Koogan, Rio de Janeiro, 320 pp.
37. Schofield CJ, Jannin J, Salvatella R 2006. The future of Chagas disease control. Trends Parasitol 22: 583-588.
38. Seneca H 1969. Experimental toxaemia in mice due to chagastoxin. Trans R Soc Trop Med Hyg 63: 535-539.
39. Seneca H, Peer P 1966. Immuno-biological properties of chagastoxin (lipopolysaccharide).Trans R Soc Trop Med Hyg 60: 610-620.
40. Siegfried Z, Berry EM, Hao S, Avraham Y 2003. Animal models in the investigation of anorexia. Physiol Behav 79: 39-45.
41. Silva AC, Bezerra LM, Aguiar TS, Tavares D, Araujo LM, Pinto CE, Ribeiro OG 2001. Effect of genetic modifications by selection for immunological tolerance on fungus infection in mice. Microbes Infect 3: 215-222.
42. Silva JS, Vespa GN, Cardoso MA, Aliberti JC, Cunha FQ 1995. Tumour necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected γ-interferon-activated macrophages. Infect Immun 63: 4862-4867.
43. Soeiro MNC, Dantas AP, Daliry A, Silva CF, Batista DGJ, Souza EM, Oliveira GM, Salomão K, Batista MM, Pacheco MGO, Silva PB, Santa-Rita RM, Barreto RFSM, Boykin DW, de Castro SL 2009. Experimental chemotherapy for Chagas disease: 15 years of research contributions from in vivo and in vitro studies. Mem Inst Oswaldo Cruz 104 (Suppl. I): 301-310.
44. Tarleton RL 1988. Tumour necrosis factor (cachectin) production during experimental Chagas disease. Clin Exp Immunol 73: 186-190.
45. Taylor TN, Greene JG, Miller GW 2010. Behavioural phenotyping of mouse models of Parkinson's disease. Behav Brain Res 211: 1-10.